For years, there have been rumblings and even research about a rare but serious condition that’s been linked to taking a GLP-1 medication. Now, the Food and Drug Administration is doing something about it.
The FDA just released a drug safety communication to warn patients and healthcare providers about the potential increased risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) when you take a GLP-1 medication. NAION is a rare condition that can lead to vision loss in one eye, and it can be permanent.
Again, this isn't the first time concerns have been raised about the risk of NAION. But it is the first time the FDA has…
Read the full article at MENSHEALTH.COM








